Christopher Yea

Insider Reports History

Entity
Individual
Location
One Kendall Square, Building 200, Suite 2203, Cambridge, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Yea:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Common Stock 90K $833K $9.26 Nov 18, 2024 Direct
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Restricted Stock Units 50K $588K $11.76 May 22, 2024 Direct
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Restricted Stock Unit 9.72K $90K $9.26 Nov 17, 2024 Direct
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Performance Stock Units 0 $0 $9.26 Nov 17, 2024 Direct
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Performance Stock Unit 0 $8.23 Nov 17, 2023 Direct

Insider Reports Filed by Christopher Yea

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Nov 17, 2024 5 -$66.6K 4 Nov 19, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. Aug 22, 2024 3 -$23.8K 4 Aug 26, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. Aug 17, 2024 5 -$85.3K 4 Aug 21, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. May 22, 2024 1 $0 4 May 24, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. May 17, 2024 6 -$137K 4 May 21, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. Feb 17, 2024 6 -$170K 4 Feb 21, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. Feb 14, 2024 1 -$599K 4 Feb 16, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. Feb 11, 2024 2 $0 4 Feb 13, 2024 CHIEF DEVELOPMENT OFFICER
KALV KalVista Pharmaceuticals, Inc. Nov 17, 2023 5 -$58.5K 4 Nov 21, 2023 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Aug 17, 2023 5 -$76.6K 4 Aug 21, 2023 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Feb 17, 2023 1 $0 4/A May 22, 2023 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Jan 11, 2023 5 -$26.4K 4 May 19, 2023 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Nov 21, 2022 3 -$6.2K 4 Nov 21, 2022 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Aug 17, 2022 3 -$17.1K 4 Aug 19, 2022 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. May 17, 2022 2 $0 4 May 19, 2022 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Nov 1, 2021 1 -$90.3K 4 Nov 3, 2021 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. Aug 2, 2021 1 -$103K 4 Aug 4, 2021 Chief Development Officer
KALV KalVista Pharmaceuticals, Inc. May 26, 2021 1 $0 4 May 28, 2021 Chief Development Officer